Literature DB >> 6311567

In vitro CRF activity of vasopressin analogs is not related to pressor activity.

W Knepel, L Homolka, M Vlaskovska.   

Abstract

The relative abilities of four vasopressin analogs to stimulate the release of beta-endorphin-like immunoreactivity from rat anterior pituitary quarters in vitro were found by the present study to be somewhat related to their relative antidiuretic activities, but to be very different from their relative pressor potencies. We conclude that vasopressin exerts its direct beta-endorphin-releasing activity via receptors with conformational requirements which are different from those of the vascular receptor type.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311567     DOI: 10.1016/0014-2999(83)90371-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function.

Authors:  J Howl; T Ismail; A J Strain; C J Kirk; D Anderson; M Wheatley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Intracellular free calcium concentration in rat anterior pituitary cells as indicated by fura-2: effect of arginine-vasopressin.

Authors:  W Knepel; C Schöfl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

3.  Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.

Authors:  R A Salata; D B Jarrett; J G Verbalis; A G Robinson
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.

Authors:  M Maggi; S Kassis; S Malozowski; V Guardabasso; D Rodbard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.